Ocular Therapeutix (OCUL) Return on Sales [ROS] (2014 - 2026)
Ocular Therapeutix (OCUL) posted Return on Sales [ROS] of -609.34% for Q2 2026, down 106.77 percentage points from -502.57% a year earlier but up 256.12 percentage points from the prior quarter.
Ocular Therapeutix (OCUL) Return on Sales [ROS] (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Ocular Therapeutix was -603.04%, down 200.44 percentage points year-over-year; for FY2025, it was -519.75%, down 250.18 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of -158.63 percentage points (FY2020 to FY2025).
- In prior years, Ocular Therapeutix's Return on Sales [ROS] was -269.57% in FY2024 (-128.61 pp), -140.96% in FY2023 (+11.78 pp), -152.74% in FY2022 (+26.56 pp) and -179.30% in FY2021 (+181.82 pp).
- Quarterly Return on Sales [ROS] has run from a low of -865.46% in Q1 2026 to a high of -127.41% in Q3 2023 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last ten quarters, with an average year-over-year change of -216.45 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2022, with a gain of 140.28 percentage points; the weakest was Q1 2025, with a drop of 383.46 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -865.46% (Q1 2026), -526.49% (Q4 2025) and -472.35% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 37.40% |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | -609.34% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -609.34% |
| Mar 31, 2026 | -865.46% |
| Dec 31, 2025 | -526.49% |
| Sep 30, 2025 | -472.35% |
| Jun 30, 2025 | -502.57% |
| Mar 31, 2025 | -597.47% |
| Dec 31, 2024 | -296.08% |
| Sep 30, 2024 | -298.20% |
| Jun 30, 2024 | -265.13% |
| Mar 31, 2024 | -214.00% |
| Dec 31, 2023 | -135.46% |
| Sep 30, 2023 | -127.41% |
| Jun 30, 2023 | -135.45% |
| Mar 31, 2023 | -168.60% |
| Dec 31, 2022 | -137.56% |
| Sep 30, 2022 | -180.06% |
| Jun 30, 2022 | -162.37% |
| Mar 31, 2022 | -135.23% |
| Dec 31, 2021 | -146.64% |
| Sep 30, 2021 | -160.69% |
Ocular Therapeutix Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();